You searched for "selection"
An overview of non-surgical treatment options for Peyronie’s disease
Peyronie’s disease (PD) is a therapeutic challenge despite the availability of several non-surgical and surgical options. Very few of these options are supported by good quality evidence according to the current American and European guidelines [1-3]. The period of plaque...
Hypercalciuria in children with monosymptomatic nocturnal enuresis
Nocturnal enuresis, defined as intermittent urinary incontinence, regardless of the presence or absence of daytime symptoms, is common. Monosymptomatic nocturnal enuresis – MSNE (no daytime symptoms) has four main causes identified with it: poor vasopressin action, nocturnal polyuria, poor arousal...The AUA Residents’ Bowl: with the help of BSoT (13-16 May 2022 • New Orleans, USA)
After successfully sitting both parts of the FRCS(Urol) examination in 2021 and still basking in the knowledge that I would never have to sit another examination again, it’s fair to say there was a certain amount of consternation when I...‘The Rise of a Specialty’ – Exhibition at the Royal Society of Medicine
The founding of the Royal Society of Medicine’s (RSM) Urology Section 100 years ago this year was crucial to the establishment of urology as a specialty in Great Britain in its own right. To mark this anniversary, earlier this year...Modern management of small renal masses
With the advent of widespread cross-sectional imaging there has been a surge in incidental detection of small renal masses (SRMs) and renal cell carcinoma (RCC) is now the seventh most common cancer in the UK. Whilst surgical excision for larger...Bladder cancer: where are we with intravesical therapies?
In the United Kingdom, almost 10,500 new cases of bladder cancer were identified in 2013, with over 5000 deaths in 2012 [1]. Seventy percent of new cases will be non-muscle invasive bladder cancer (NMIBC) at diagnosis and therefore will be...BAUS BPH Meeting 2022
BAUS BPH Meeting 2022 By Rachel McLennan, Urology Registrar (ST5), Monklands Hospital, Glasgow. Over the last decade the number of treatment options for managing benign prostatic hyperplasia / lower urinary tract symptoms (BPH/LUTS) has grown substantially. Despite increased uptake of...
Metabolic syndrome and prostate cancer recurrence in a veterans’ cohort
This study explored the relationship between metabolic syndrome and localised prostate cancer recurrence in patients who had received active treatment (external beam radiation therapy – EBRT, radical retropubic prostatectomy – RRP, or brachytherapy). The definition of metabolic syndrome adopted was...
